Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Tim Fitzpatrick, CEO and Co-Founder of IKONA Health, discusses their innovative kidney education platform designed for improved learning outcomes.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
David Cho is CEO of IKONA Partners
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Precious Metals Outlook: Dynamics and Risks in PGM Markets
00:10:00
Vantage Towers' M&A Ambitions: CFO Thomas Reisten on Industry Growth and Expansion | Thomas Reisten, CFO , Vantage Towers AG.
00:10:00
Icetana CEO Matt Macfarlane on Advanced Tech Solutions | Matt Macfarlan , CEO , Icetana Ltd.
00:10:00
From Cargill to Leading Global Alternatives - A Journey of Value Investing, Leadership, and Empowering Diversity in Finance
00:10:00
GoGold: Mexican Mining Company with Cash-Flowing Asset and Promising Los Rico's Project.
00:10:00
Resolving Cross-Border Transfer Pricing Disputes: Insights from Clark Armitage on the 'GILTI Conscience' Podcast | John Slate - Founder of Skadden
00:10:00
ROCA Industry Achieves 75% EBITDA Growth in First Half of 2024 | IonuČ› Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Understanding Capital Contribution in LLCs and Corporations
00:10:00
Mark Partin of BlackLine on Navigating the Future of Finance and Customer Relationships | Mark Partin, CFO, BlackLine Inc.
00:10:00
Amarillo Gold: Advancing Brazilian Gold Projects with Confidence
00:10:00
Building Developer-First and Open Source Businesses|Lenny Pruss,General Partner,Amplify Partners
00:10:00
CEO and CFO Present FY Results Released on June 14 | Adam Vicary - Chief Executive Officer of Castings PLC